HIGHLIGHTS
- who: Brandon Travis Wiggins and collaborators from the Department of Internal Medicine, Ascension Genesys Hospital, Grand Blanc, MI, USA have published the research: Medication-Induced Factor V Inhibition in the Setting of Refractory Coagulopathy, in the Journal: (JOURNAL)
- future: Other studies are ongoing and it brings up an interesting consideration for future research and guidelines but as of now it is not standard of care to guide transfusions in cirrhotic patients with TEG.
SUMMARY
Factor V Inhibition in the Setting of Acquired Factor V inhibition is a rare, but potentially life . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.